BCR-ABL1 tyrosine kinase inhibitor-associated thyroid dysfunction: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature.

HOME
>
論文・技術情報
>
BCR-ABL1 tyrosine kinase inhibitor-associated thyroid dysfunction: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature.

アブストラクト
ジャーナル名	American journal of hematology
Pubmed追加日	2020/9/13
投稿者	Patel, Shital; Nayernama, Afrouz; Jones, Steven Christopher; de Claro, Romeo Angelo; Waldron, Peter E
組織名	Division of Pharmacovigilance, Office of Surveillance and Epidemiology, U.S. Food;and Drug Administration, Silver Spring, Maryland.;Division of Hematologic Malignancies I, Office of Oncologic Diseases, U.S. Food
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/32918288/